Cell cycle regulation of DNA polymerase beta in rotenone-based Parkinson's disease models

PLoS One. 2014 Oct 10;9(10):e109697. doi: 10.1371/journal.pone.0109697. eCollection 2014.

Abstract

In Parkinson's disease (PD), neuronal cells undergo mitotic catastrophe and endoreduplication prior to cell death; however, the regulatory mechanisms remain to be defined. In this study, we investigated cell cycle regulation of DNA polymerase β (poly β) in rotenone-based dopaminergic cellular and animal models. Incubation with a low concentration (0.25 µM) of rotenone for 1.5 to 7 days resulted in a flattened cell body and decreased DNA replication during S phase, whereas a high concentration (2 µM) of rotenone exposure resulted in enlarged, multi-nucleated cells and converted the mitotic cycle into endoreduplication. Consistently, DNA poly β, which is mainly involved in DNA repair synthesis, was upregulated to a high level following exposure to 2 µM rotenone. The abrogation of DNA poly β by siRNA transfection or dideoxycytidine (DDC) treatment attenuated the rotenone-induced endoreduplication. The cell cycle was reactivated in cyclin D-expressing dopaminergic neurons from the substantia nigra (SN) of rats following stereotactic (ST) infusion of rotenone. Increased DNA poly β expression was observed in the substantia nigra pars compacta (SNc) and the substantia nigra pars reticulate (SNr) of rotenone-treated rats. Collectively, in the in vitro model of rotenone-induced mitotic catastrophe, the overexpression of DNA poly β promotes endoreduplication; in the in vivo model, the upregulation of DNA poly β and cell cycle reentry were also observed in the adult rat substantia nigra. Therefore, the cell cycle regulation of DNA poly β may be involved in the pathological processes of PD, which results in the induction of endoreduplication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle / drug effects*
  • Cell Cycle / genetics
  • Cell Cycle Checkpoints
  • Cell Death / drug effects
  • DNA Polymerase beta / genetics*
  • Dopaminergic Neurons / drug effects*
  • Dopaminergic Neurons / metabolism
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / genetics*
  • Parkinson Disease, Secondary / metabolism
  • Rats
  • Rotenone / pharmacology*
  • Substantia Nigra / drug effects*
  • Substantia Nigra / metabolism

Substances

  • Rotenone
  • DNA Polymerase beta

Grants and funding

This work was supported by grants (No. 81071021, No. 31171211, No. 81100958 and No. 81200983) from the National Natural Science Foundation of China (to Tao Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.